Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Short-term Investments (2017 - 2025)

Inspire Medical Systems' Short-term Investments history spans 9 years, with the latest figure at $203.5 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 31.12% year-over-year to $203.5 million; the TTM value through Dec 2025 reached $203.5 million, down 31.12%, while the annual FY2025 figure was $203.5 million, 31.12% down from the prior year.
  • Short-term Investments for Q4 2025 was $203.5 million at Inspire Medical Systems, down from $209.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $315.3 million in Q1 2025 and bottomed at $9.7 million in Q3 2022.
  • The 5-year median for Short-term Investments is $198.7 million (2025), against an average of $157.7 million.
  • The largest annual shift saw Short-term Investments crashed 68.84% in 2022 before it soared 2698.47% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $31.3 million in 2021, then crashed by 68.62% to $9.8 million in 2022, then skyrocketed by 2698.47% to $274.8 million in 2023, then increased by 7.48% to $295.4 million in 2024, then plummeted by 31.12% to $203.5 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Short-term Investments are $203.5 million (Q4 2025), $209.7 million (Q3 2025), and $194.0 million (Q2 2025).